Clinical trials
Withdrawn Phase 2 Biliary Tract Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| ASLAN Pharmaceuticals | 1 |
| Ambrx, Inc. | 1 |
| Georgetown University | 1 |
| Institut Bergonié | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Karolinska Institutet | 1 |
| Karus Therapeutics Limited | 1 |
| New Mexico Cancer Research Alliance | 1 |
| Samsung Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 13 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Gallbladder Neoplasms | 2 |
| Bites and Stings | 1 |
| Breast Neoplasms | 1 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
| Duodenal Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Jaundice | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.